Cargando…
Biallelic CYP24A1 variants presenting during pregnancy: clinical and biochemical phenotypes
INTRODUCTION: Inactivating mutations in CYP24A1, encoding vitamin D-24-hydroxylase, can lead to an accumulation of active vitamin D metabolites and consequent hypercalcaemia. Patient (infantile and adult) presentation is varied and includes mild-severe hypercalcaemia, hypercalciuria, nephrocalcinosi...
Autores principales: | Griffin, Tomás P, Joyce, Caroline M, Alkanderi, Sumaya, Blake, Liam M, O’Keeffe, Derek T, Bogdanet, Delia, Islam, Md Nahidul, Dennedy, Michael C, Gillan, John E, Morrison, John J, O’Brien, Timothy, Sayer, John A, Bell, Marcia, O’Shea, Paula M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354719/ https://www.ncbi.nlm.nih.gov/pubmed/32375123 http://dx.doi.org/10.1530/EC-20-0150 |
Ejemplares similares
-
The Oral Glucose Tolerance Test—Is It Time for a Change?—A Literature Review with an Emphasis on Pregnancy
por: Bogdanet, Delia, et al.
Publicado: (2020) -
Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential
por: Griffin, Tomás Patrick, et al.
Publicado: (2019) -
Developing a core outcome set for the treatment of pregnant women with pregestational diabetes—a study protocol
por: Kgosidialwa, Oratile, et al.
Publicado: (2020) -
Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) – protocol for prospective cohort study
por: Bogdanet, D., et al.
Publicado: (2020) -
Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review
por: Bogdanet, Delia, et al.
Publicado: (2021)